Using genetic information to reduce hospital readmissions caused by medication issues
Integrative Analyses of Clinical Pharmacogenetic Data to Prevent Hospital Readmission in Real-World Health Systems
This study is looking at how your genes might affect how you respond to medications, with the goal of helping to prevent hospital visits and readmissions caused by bad reactions to drugs, and it’s designed for patients who want to understand their medication safety better.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Endeavor Health Clinical Operations NIH-funded |
| Lab location | 1 site (Evanston, United States) |
| Project ID | NIH-11030241 on NIH RePORTER |
What this research studies
This research investigates how genetic factors influence patients' responses to medications and aims to reduce hospital readmissions due to adverse drug reactions. By analyzing clinical pharmacogenetic data, the study seeks to identify patients at higher risk for medication-related complications, allowing for targeted preemptive genotyping. The research will be conducted within two healthcare systems, focusing on a diverse patient population to evaluate the impact of gene-drug interactions on hospital visits and readmissions over a two-year period.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients who have experienced adverse drug reactions or hospital readmissions related to medication issues.
Not a fit: Patients who do not take medications or have no history of adverse drug reactions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to personalized medication plans that significantly reduce the risk of hospital readmissions for patients.
How similar studies have performed: Previous research has shown promising results in using pharmacogenetics to improve medication safety and reduce hospital readmissions, indicating that this approach has potential for success.
Where this research is happening
Evanston, United States
- Endeavor Health Clinical Operations — Evanston, United States (Active)
Researchers
- Principal investigator: David, Sean P. — Endeavor Health Clinical Operations
- Study coordinator: David, Sean P.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.